GlassScriptPhysician profile
Sarah P Ullah
NPI 1982947230
$1,469.22
in general payments reported to CMS, 2019-2025
11 companies · $722 in 2025
The $722 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.27 · 2021: $208 · 2023: $203 · 2024: $279 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Entertainment: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.53 |
| Entertainment | $218.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $344.11 | 2025 | Hydrus Microstent, Clareon, Precision7 |
| Nova Eye, INC. | $218.09 | 2025 | |
| Abbvie INC. | $208.78 | 2023-2025 | Durysta, Lumigan |
| Glaukos Corporation | $193.11 | 2024 | Iaccess Precision Blade, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| New World Medical,INC. | $111.05 | 2021-2025 | Via360, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Sight Sciences, INC. | $102.68 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ivantis, INC | $56.27 | 2020 | |
| Bausch & Lomb Americas INC. | $44.71 | 2023-2025 | Stellaris, Envista Mx60 Iol, Vyzulta |
| Thea Pharma INC. | $41.46 | 2023 | Iyuzeh |
| Coopervision INC. | $23.96 | 2024 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.